{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T15:35:40Z","timestamp":1784475340304,"version":"3.55.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["DT15S\/00166"],"award-info":[{"award-number":["DT15S\/00166"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/01055"],"award-info":[{"award-number":["PI15\/01055"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","award":["RD012\/0021\/0032"],"award-info":[{"award-number":["RD012\/0021\/0032"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"name":"REDINREN-FEDER"},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2013-45784-R"],"award-info":[{"award-number":["SAF2013-45784-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["IPT-2012-0779-010000"],"award-info":[{"award-number":["IPT-2012-0779-010000"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.pharmthera.2016.07.011","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T21:58:11Z","timestamp":1470175091000},"page":"132-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Mechanisms of triple whammy acute kidney injury"],"prefix":"10.1016","volume":"167","author":[{"given":"Laura","family":"Prieto-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Pericacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Sancho-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Mart\u00ednez-Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"L\u00f3pez-Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"L\u00f3pez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2016.07.011_bb0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/014107680109401005","article-title":"Nephrotoxicity in the elderly due to co-prescription of angiotensin converting enzyme inhibitors and nonsteroidal anti-inflammatory drugs","volume":"94","author":"Adhiyaman","year":"2001","journal-title":"J R Soc Med"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fphys.2013.00194","article-title":"Purinergic signaling in inflammatory renal disease","volume":"4","author":"Arulkumaran","year":"2013","journal-title":"Front Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0015","first-page":"F333","article-title":"Anatomy of the juxtaglomerular apparatus","volume":"237","author":"Barajas","year":"1979","journal-title":"Am J Phys"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0020","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1590\/S0066-782X2010000400019","article-title":"Nonsteroidal anti-inflammatory drugs: cardiovascular, cerebrovascular and renal effects","volume":"94","author":"Batlouni","year":"2010","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0025","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/01.HYP.0000145180.38707.84","article-title":"Pathophysiology of hypertensive renal damage: implications for therapy","volume":"44","author":"Bidani","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.109.133777","article-title":"Protective importance of the myogenic response in the renal circulation","volume":"54","author":"Bidani","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0b013e32835b36c1","article-title":"Renal microvascular dysfunction, hypertension and CKD progression","volume":"22","author":"Bidani","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000020665","article-title":"Preferential COX-2 inhibitor, meloxicam, compromises renal perfusion in euvolemic and hypovolemic rats","volume":"8","author":"Birck","year":"2000","journal-title":"Exp Nephrol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0045","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00424-008-0498-1","article-title":"Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption","volume":"456","author":"Boone","year":"2008","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0050","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/ndt\/gfg622","article-title":"Acute renal failure and hyperkalaemia associated with cyclooxygenase-2 inhibitors","volume":"19","author":"Braden","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/sarh.2002.37216","article-title":"Anti-inflammatory agents and renal function","volume":"32","author":"Brater","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0060","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.physiol.63.1.579","article-title":"G protein-coupled prostanoid receptors and the kidney","volume":"63","author":"Breyer","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/oxfordjournals.ndt.a092076","article-title":"Acute renal failure after the use of angiotensin-converting-enzyme inhibitors in patients without renal artery stenosis","volume":"7","author":"Bridoux","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0070","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0075","first-page":"13","article-title":"The intrarenal renin-angiotensin system","volume":"13","author":"Burns","year":"1993","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/physrev.00042.2012","article-title":"Renal autoregulation in health and disease","volume":"95","author":"Carlstr\u00f6m","year":"2015","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0085","doi-asserted-by":"crossref","first-page":"F412","DOI":"10.1152\/ajprenal.00211.2010","article-title":"Adenosine A(2) receptors modulate tubuloglomerular feedback","volume":"299","author":"Carlstr\u00f6m","year":"2010","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0090","doi-asserted-by":"crossref","first-page":"F518","DOI":"10.1152\/ajprenal.00338.2002","article-title":"General inhibition of renocortical cyclooxygenase-2 expression by the renin-angiotensin system","volume":"284","author":"Castrop","year":"2003","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.HYP.0000116221.27079.ea","article-title":"Cyclooxygenases, the kidney, and hypertension","volume":"43","author":"Cheng","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0100","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients","volume":"16","author":"Chertow","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1476-5381.1988.tb11653.x","article-title":"Effects of furosemide on renal haemodynamics and proximal tubular sodium reabsorption in conscious rats","volume":"95","author":"Christensen","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11906-002-0038-x","article-title":"Renal afferents and hypertension","volume":"4","author":"Ciriello","year":"2002","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0115","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/ndt\/gft405","article-title":"Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery","volume":"28","author":"Coca","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1152\/physrev.1992.72.1.231","article-title":"Long-term control of arterial blood pressure","volume":"72","author":"Cowley","year":"1992","journal-title":"Physiol Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2016.07.011_bb0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/XXXIV.suppl_1.25","article-title":"Non-steroidal anti-inflammatory drugs and renal function","volume":"34","author":"Delmas","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0130","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/j.1523-1755.2004.66033.x","article-title":"Temporal adaptation of tubuloglomerular feedback: effects of COX-2","volume":"66","author":"Deng","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0135","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1440-1681.2004.04002.x","article-title":"Differential neural control of glomerular ultrafiltration","volume":"31","author":"Denton","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.HYP.0000113047.47711.fa","article-title":"The sympathetic nervous system and hypertension: recent developments","volume":"43","author":"DiBona","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","article-title":"Neural control of renal function","volume":"77","author":"DiBona","year":"1997","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0150","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.2015.101","article-title":"Combined use of nonsteroidal anti-inflammatory drugs with diuretics and\/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury","volume":"88","author":"Dreischulte","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0155","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/ki.1980.179","article-title":"Renal effects of drugs that inhibit prostaglandin synthesis","volume":"18","author":"Dunn","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0160","first-page":"F95","article-title":"Hormonal modulation of glomerular function","volume":"244","author":"Dworkin","year":"1983","journal-title":"Am J Phys"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1113\/jphysiol.1977.sp011916","article-title":"Adaptation of the human carotid baroreceptor-cardiac reflex","volume":"269","author":"Eckberg","year":"1977","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0170","first-page":"F274","article-title":"Renal microvascular effects of vasopressin and vasopressin antagonists","volume":"256","author":"Edwards","year":"1989","journal-title":"Am J Phys"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.mnh.0000441150.17202.be","article-title":"Are diuretics harmful in the management of acute kidney injury?","volume":"23","author":"Ejaz","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0180","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.HYP.16.4.363","article-title":"Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture","volume":"16","author":"Erdos","year":"1990","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0185","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.clinthera.2008.03.006","article-title":"The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study","volume":"30","author":"Esnault","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0190","doi-asserted-by":"crossref","first-page":"F1035","DOI":"10.1152\/ajprenal.00054.2011","article-title":"A major role for the EP4 receptor in regulation of renin","volume":"301","author":"Facemire","year":"2011","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0195","doi-asserted-by":"crossref","first-page":"e34187","DOI":"10.1371\/journal.pone.0034187","article-title":"Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: A cohort study","volume":"7","author":"Fournier","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0200","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3109\/0886022X.2014.917943","article-title":"More on the \u201cTriple Whammy\u201d: Antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury \u2014 A case\/non-case study in the French pharmacovigilance database","volume":"36","author":"Fournier","year":"2014","journal-title":"Ren Fail"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0205","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2796.2003.01146.x","article-title":"Adverse renal effects of anti-inflammatory agents: Evaluation of selective and nonselective cyclooxygenase inhibitors","volume":"253","author":"Gambaro","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nefro.2015.05.021","article-title":"Fracaso renal agudo secundario a combinaci\u00f3n de inhibidores del sistema renina-angiotensina, diur\u00e9ticos y AINES. \u201cLa Triple Whammy\u201d","volume":"35","author":"Garc\u00eda Camin","year":"2015","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0215","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.CIR.90.1.220","article-title":"Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition","volume":"90","author":"Good","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MNH.0b013e32834d9d75","article-title":"The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function","volume":"21","author":"Green","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0225","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/BF00382688","article-title":"Autoregulation of the glomerular filtration rate and the single-nephron glomerular filtration rate despite inhibition of tubuloglomerular feedback in rats chronically volume-expanded by deoxycorticosterone acetate","volume":"416","author":"H\u00e4berle","year":"1990","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0230","first-page":"8","article-title":"The renin-angiotensin system: Renal actions and blood pressure regulation","volume":"17","author":"Hall","year":"1991","journal-title":"Compr Ther"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0235","first-page":"48","article-title":"Role of the renin-angiotensin system in control of sodium excretion and arterial pressure","volume":"591","author":"Hall","year":"1990","journal-title":"Acta Physiol Scand Suppl"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.physiol.70.113006.100614","article-title":"Physiological regulation of prostaglandins in the kidney","volume":"70","author":"Hao","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0952-3278(02)00231-4","article-title":"COX-2 inhibition potentiates the antiproteinuric effect of enalapril in uninephrectomized SHR","volume":"68","author":"Harding","year":"2003","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0250","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-201X.2003.01101.x","article-title":"Interactions between COX-2 and the renin-angiotensin system in the kidney","volume":"177","author":"Harris","year":"2003","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0255","first-page":"139","article-title":"Physiologic and pathophysiologic roles of cyclooxygenase-2 in the kidney","volume":"124","author":"Harris","year":"2013","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0260","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.2001.281.1.F1","article-title":"Physiological regulation of cyclooxygenase-2 in the kidney","volume":"281","author":"Harris","year":"2001","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0265","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cphy.c100077","article-title":"Cyclooxygenase metabolites in the kidney","volume":"1","author":"Harris","year":"2011","journal-title":"Compr Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0270","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1172\/JCI117620","article-title":"Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction","volume":"94","author":"Harris","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0275","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-201X.2004.01329.x","article-title":"Cyclooxygenase-2 and the renal renin-angiotensin system","volume":"181","author":"Harris","year":"2004","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0280","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00004872-199502000-00011","article-title":"Role of the adrenal medulla in control of blood pressure and renal function during frusemide-induced volume depletion","volume":"13","author":"Hasbak","year":"1995","journal-title":"J Hypertens"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2016.07.011_bb0285","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1097\/00005344-198400061-00028","article-title":"The renin-angiotensin system and sodium homeostasis","volume":"6","author":"Hollenberg","year":"1984","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0290","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/ph3072291","article-title":"Nonsteroidal anti-inflammatory drugs and the kidney","volume":"3","author":"H\u00f6rl","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0295","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1681\/ASN.V16845","article-title":"Angiotensin-converting enzyme inhibitor-induced renal failure: Causes, consequences, and diagnostic uses","volume":"1","author":"Hricik","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0300","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/B978-0-444-53491-0.00017-1","article-title":"Autonomic regulation of kidney function","volume":"117","author":"Johns","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0305","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/cphy.c100043","article-title":"Neural control of renal function","volume":"1","author":"Johns","year":"2011","journal-title":"Compr Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0310","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/014107680109401228","article-title":"Nephrotoxicity in the elderly due to co-prescription of ACE inhibitors and NSAIDs","volume":"94","author":"Jolobe","year":"2001","journal-title":"J R Soc Med"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0315","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1046\/j.1523-1755.2001.00988.x","article-title":"Inhibition of COX-2 counteracts the effects of diuretics in rats","volume":"60","author":"Kammerl","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0320","first-page":"251","article-title":"Diuretics in acute kidney injury","volume":"75","author":"Karajala","year":"2009","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0325","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0272-6386(12)81128-0","article-title":"Community-acquired acute renal failure","volume":"17","author":"Kaufman","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0330","first-page":"479","article-title":"Mechanisms and consequences of proteinuria","volume":"54","author":"Kaysen","year":"1986","journal-title":"Lab Investig"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0335","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/ndt\/gfu016","article-title":"The economic impact of acute kidney injury in England","volume":"29","author":"Kerr","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0340","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5049\/EBP.2008.6.1.35","article-title":"Renal effects of prostaglandins and cyclooxygenase-2 inhibitors","volume":"6","author":"Kim","year":"2008","journal-title":"Electrolyte Blood Press"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0345","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-62-5-1003","article-title":"Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans","volume":"62","author":"Kimura","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0350","first-page":"F936","article-title":"Effects of atrial natriuretic peptide on renal arterioles: Morphometric analysis using microvascular casts","volume":"259","author":"Kimura","year":"1990","journal-title":"Am J Phys"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0355","first-page":"193","article-title":"Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletion","volume":"131","author":"Kistler","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0360","doi-asserted-by":"crossref","first-page":"F1453","DOI":"10.1152\/ajprenal.00426.2007","article-title":"Dynamic myogenic autoregulation in the rat kidney: A whole-organ model","volume":"294","author":"Kleinstreuer","year":"2008","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0365","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.2174\/1381612811319170009","article-title":"Angiotensin II blockade and renal protection","volume":"19","author":"Kobori","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0370","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1136\/bmj.289.6457.1492","article-title":"Influence of non-steroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension","volume":"289","author":"Koopmans","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0375","doi-asserted-by":"crossref","DOI":"10.4199\/C00034ED1V01Y201106ISP022","article-title":"Neural control of renal function","author":"Kopp","year":"2011"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0380","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10157-009-0214-2","article-title":"Effects of selective Cox-2 inhibitor, rofecoxib, alone or combination with furosemide on renal functions and renal Cox-2 expression in rats","volume":"14","author":"Kose","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0385","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000074551","article-title":"Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study","volume":"27","author":"Kramer","year":"2004","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0390","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/qjmed\/94.2.89","article-title":"Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus","volume":"94","author":"Kvetny","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0395","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00007691-199504000-00007","article-title":"Effect of diuretic drugs on creatinine clearance determination","volume":"17","author":"Lam","year":"1995","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0400","first-page":"F230","article-title":"Chronic administration of furosemide augments renal weight and glomerular capillary pressure in normal rats","volume":"275","author":"Lane","year":"1998","journal-title":"Am J Phys"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0405","doi-asserted-by":"crossref","first-page":"e8525","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case\u2013control study","volume":"346","author":"Lapi","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0410","first-page":"739","article-title":"Renal functional response to captopril during diuretic therapy","volume":"33","author":"Lee","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0415","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.0306-5251.2004.2188.x","article-title":"Drug combinations and impaired renal function \u2014 The \u2018triple whammy\u2019","volume":"59","author":"Loboz","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0420","doi-asserted-by":"crossref","first-page":"R828","DOI":"10.1152\/ajpregu.00591.2004","article-title":"Recent insights into the interactions between the baroreflex and the kidneys in hypertension","volume":"288","author":"Lohmeier","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0425","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pharmthera.2005.08.002","article-title":"The lord of the ring: mandatory role of the kidney in drug therapy of hypertension","volume":"111","author":"L\u00f3pez-Hernandez","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0430","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0014-2999(87)90371-2","article-title":"Adenosine induces a calcium-dependent glomerular contraction","volume":"134","author":"L\u00f3pez-Novoa","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0435","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/01.RES.0000024262.11534.18","article-title":"Renal myogenic response: Kinetic attributes and physiological role","volume":"90","author":"Loutzenhiser","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0440","doi-asserted-by":"crossref","first-page":"R1153","DOI":"10.1152\/ajpregu.00402.2005","article-title":"Renal autoregulation: New perspectives regarding the protective and regulatory roles of the underlying mechanisms","volume":"290","author":"Loutzenhiser","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0445","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0022-3565(25)22094-8","article-title":"Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney","volume":"246","author":"Loutzenhiser","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0450","first-page":"562","article-title":"Influence of plasma renin content, intrarenal angiotensin II, captopril, and calcium channel blockers on the vasoconstriction and renin release promoted by adenosine in the kidney","volume":"106","author":"Mac\u00edas-Nu\u00f1ez","year":"1985","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0455","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1523-1755.2001.00466.x","article-title":"Furosemide stimulates macula densa cyclooxygenase-2 expression in rats","volume":"59","author":"Mann","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0460","doi-asserted-by":"crossref","first-page":"R624","DOI":"10.1152\/ajpregu.00324.2010","article-title":"Angiotensin II-stimulated secretion of arginine vasopressin is inhibited by atrial natriuretic peptide in humans","volume":"300","author":"Matsukawa","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0465","doi-asserted-by":"crossref","first-page":"F1782","DOI":"10.1152\/ajprenal.00513.2006","article-title":"COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys","volume":"292","author":"Matzdorf","year":"2007","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0470","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2460\/ajvr.67.4.715","article-title":"Effects of administration of fluids and diuretics on glomerular filtration rate, renal blood flow, and urine output in healthy awake cats","volume":"67","author":"McClellan","year":"2006","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0475","first-page":"1461","article-title":"Acute nephrotoxicity of NSAID from the foetus to the adult","volume":"15","author":"Musu","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0480","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jat.2999","article-title":"Usefulness of urinary kidney injury molecule-1 (Kim-1) as a biomarker for cisplatin-induced sub-chronic kidney injury","volume":"35","author":"Nan-Ya","year":"2015","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0485","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20070089","article-title":"Prostaglandins in the kidney: Developments since Y2K","volume":"113","author":"Nasrallah","year":"2007","journal-title":"Clin Sci (Lond)"},{"issue":"Pt 3","key":"10.1016\/j.pharmthera.2016.07.011_bb0490","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1042\/bj2820871","article-title":"Adenosine stimulates Ca2+ fluxes and increases cytosolic free Ca2+ in cultured rat mesangial cells","volume":"282","author":"Olivera","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0495","doi-asserted-by":"crossref","first-page":"C840","DOI":"10.1152\/ajpcell.1992.262.4.C840","article-title":"Effect of adenosine A1 and A2 agonists and antagonists on cAMP and Ca2+ in cultured rat mesangial cells","volume":"262","author":"Olivera","year":"1992","journal-title":"Am J Phys"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0500","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ki.1989.126","article-title":"Adenosine induces mesangial cell contraction by an A1-type receptor","volume":"35","author":"Olivera","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0505","doi-asserted-by":"crossref","first-page":"f678","DOI":"10.1136\/bmj.f678","article-title":"The nephrotoxic \u201ctriple whammy\u201d of combining diuretics, ACE inhibitors, and NSAIDs [corrected]","volume":"346","author":"Onuigbo","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0510","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4103\/1119-3077.141440","article-title":"\u201cQuadruple whammy\u201d \u2014 A preventable newly described syndrome of post-operative AKI in CKD II and CKD III patients on combination \u201cTriple whammy\u201dmedications: A Mayo Clinic Health System, Eau Claire, Wisconsin experience","volume":"17","author":"Onuigbo","year":"2014","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0515","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra020676","article-title":"Renal dysfunction complicating the treatment of hypertension","volume":"347","author":"Palmer","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0520","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2125.1989.tb05397.x","article-title":"A comparison of the effects of ibuprofen and indomethacin upon renal haemodynamics and electrolyte excretion in the presence and absence of frusemide","volume":"27","author":"Passmore","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0525","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2125.1990.tb03641.x","article-title":"The effects of ibuprofen and indomethacin on renal function in the presence and absence of frusemide in healthy volunteers on a restricted sodium diet","volume":"29","author":"Passmore","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0530","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00467-007-0721-x","article-title":"Nephrotoxicity as a cause of acute kidney injury in children","volume":"23","author":"Patzer","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2016.07.011_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0773.1999.tb01946.x","article-title":"Interactions between furosemide and the renal sympathetic nerves","volume":"84","author":"Petersen","year":"1999","journal-title":"Pharmacol Toxicol"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2016.07.011_bb0540","first-page":"559","article-title":"Nephrotoxicity testing in vitro\u2014What we know and what we need to know","volume":"106","author":"Pfaller","year":"1998","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0545","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-3-540-68964-5_15","article-title":"Natriuretic peptides: Their structures, receptors, physiologic functions and therapeutic applications","author":"Potter","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0550","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev-physiol-021909-135825","article-title":"Intrarenal purinergic signaling in the control of renal tubular transport","volume":"72","author":"Praetorius","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0555","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2125.1997.00632.x","article-title":"Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?","volume":"44","author":"Pritchard","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0560","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneph.2013.232","article-title":"Fluid management for the prevention and attenuation of acute kidney injury","volume":"10","author":"Prowle","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0565","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nhtm.2015.05.002","article-title":"An old term in search for a new meaning within the evolving concept of acute kidney injury","volume":"2","author":"Sancho-Mart\u00ednez","year":"2015","journal-title":"New Horiz Transl Med"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0570","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/ndt\/16.9.1735","article-title":"Cyclooxygenase-2 and macula densa control of renin secretion","volume":"16","author":"Schnermann","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0575","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/hc4101.096153","article-title":"Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the council on the kidney in cardiovascular disease and the Council for High Blood Pressure Research of the American Heart Association","volume":"104","author":"Schoolwerth","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0580","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00424-014-1668-y","article-title":"Salt feedback on the renin-angiotensin-aldosterone system","volume":"467","author":"Schweda","year":"2015","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0585","first-page":"693","article-title":"Effects of furosemide on blood pressure in anephric rats","volume":"66","author":"Sechi","year":"1990","journal-title":"Boll Soc Ital Biol Sper"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0590","doi-asserted-by":"crossref","first-page":"F1357","DOI":"10.1152\/ajprenal.00649.2013","article-title":"Theoretical assessment of renal autoregulatory mechanisms","volume":"306","author":"Sgouralis","year":"2014","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0595","doi-asserted-by":"crossref","first-page":"R868","DOI":"10.1152\/ajpregu.00579.2011","article-title":"Renal responses to furosemide are significantly attenuated in male sheep at 6months of age following fetal uninephrectomy","volume":"302","author":"Singh","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0600","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000086569","article-title":"Tacrolimus and nonsteroidal anti-inflammatory drugs: An association to be avoided","volume":"25","author":"Soubhia","year":"2005","journal-title":"Am J Nephrol"},{"issue":"Suppl. 4","key":"10.1016\/j.pharmthera.2016.07.011_bb0605","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00005344-198906144-00006","article-title":"Role of the renin-angiotensin system in the regulation of glomerular filtration","volume":"14","author":"Sraer","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2016.07.011_bb0610","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003495-199300461-00066","article-title":"Renal effects of nimesulide in furosemide-treated subjects","volume":"46","author":"Steinh\u00e4uslin","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0615","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/j.1523-1755.2005.00676.x","article-title":"Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers","volume":"68","author":"Stichtenoth","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0620","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2125.1993.tb04149.x","article-title":"Non-steroidal anti-inflammatory drugs and angiotensin converting enzyme inhibitors: A commonly prescribed combination with variable effects on renal function","volume":"35","author":"Sturrock","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0625","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.01900214","article-title":"AKI in hospitalized children: Comparing the pRIFLE, AKIN, and KDIGO definitions","volume":"10","author":"Sutherland","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0630","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1996.101","article-title":"Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles","volume":"49","author":"Tamaki","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0635","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: Renin-angiotensin-aldosterone system alterations","volume":"116","author":"Te Riet","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0640","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5694\/j.1326-5377.2000.tb125548.x","article-title":"Diuretics, ACE inhibitors and NSAIDs\u2014The triple whammy","volume":"172","author":"Thomas","year":"2000","journal-title":"Med J Aust"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0645","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/ki.2014.328","article-title":"The definition of acute kidney injury and its use in practice","volume":"87","author":"Thomas","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0650","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1046\/j.1523-1755.1998.06713.x","article-title":"Resetting protects efficiency of tubuloglomerular feedback","volume":"67","author":"Thomson","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0655","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1007122706770","article-title":"Acute effects of the anti-inflammatory cyclooxygenase-2 selective inhibitor, flosulide, on renal plasma flow and glomerular filtration rate in rats","volume":"25","author":"Turull","year":"2001","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0660","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000313775","article-title":"The meaning of transient azotemia","volume":"165","author":"Uchino","year":"2010","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0665","first-page":"169","article-title":"Tubuloglomerular feedback and the control of glomerular filtration rate","volume":"18","author":"Vallon","year":"2003","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0670","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1179\/acb.2007.077","article-title":"Acute kidney injury, length of stay, and costs in patients hospitalized in the intensive care unit","volume":"2","author":"Vandijck","year":"2007","journal-title":"Acta Clin Belg Suppl"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0675","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/bmj.281.6242.702","article-title":"Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin","volume":"281","author":"Watkins","year":"1980","journal-title":"Br Med J"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2016.07.011_bb0680","first-page":"SI53","article-title":"Renal effects of nonselective NSAIDs and coxibs","volume":"69","author":"Weir","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0685","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.clinthera.2007.09.019","article-title":"Effects of renin-angiotensin system inhibition on end-organ protection: Can we do better?","volume":"29","author":"Weir","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0690","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/S0002-9343(99)00113-8","article-title":"Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications","volume":"106","author":"Whelton","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0695","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/j.1552-4604.1991.tb03743.x","article-title":"Nonsteroidal anti-inflammatory drugs: Effects on kidney function","volume":"31","author":"Whelton","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0700","first-page":"372","article-title":"Thromboxane synthase inhibition enhances furosemide-induced renal vasodilation","volume":"16","author":"Wilson","year":"1993","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.pharmthera.2016.07.011_bb0705","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3109\/0886022X.2014.917560","article-title":"Diuretics associated acute kidney injury: Clinical and pathological analysis","volume":"36","author":"Wu","year":"2014","journal-title":"Ren Fail"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372581630136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372581630136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:39:26Z","timestamp":1749037166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372581630136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":141,"alternative-id":["S016372581630136X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.07.011","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of triple whammy acute kidney injury","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}